+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Continuous Manufacturing Market by Product, Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4990164
  • Report
  • December 2019
  • Region: Global
  • 245 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Coperion GmbH
  • GEA Group AG
  • Glatt GmbH
  • Korsch AG
  • Thermo Fisher Scient
  • MORE
The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026. Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.

The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.

Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.

Moreover, the CM process is more time-efficient, reduces energy needs, helps to an increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four major regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Product
  • Integrated Continuous Systems
  • Semicontinuous Systems
  • Control & Software
By Application Type
  • Final Drug Product Manufacturing
  • API Manufacturing
By End User
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Bosch Packaging Technology
  • Coperion GmbH
  • GEA Group AG
  • Gebrüder Lödige Maschinenbau GmbH
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Munson Machinery Company, Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Coperion GmbH
  • GEA Group AG
  • Glatt GmbH
  • Korsch AG
  • Thermo Fisher Scient
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. CXO Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
3.3.1.2. Advantages offered By Continuous Manufacturing Systems
3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems
3.3.2. Restraint
3.3.2.1. Poor Demand In Under Developed Countries
3.3.3. Opportunities
3.3.3.1. Growth Opportunities In Emerging Markets
3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Integrated Continuous Systems
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Semi-Continuous Systems
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Control & Software
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Final Drug Product Manufacturing
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Api Manufacturing
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Pharmaceutical Companies
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Contract Manufacturing Organizations
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Others
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.2. Canada
7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.3. Mexico
7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User
7.2.3. North America Market Size And Forecast, By Product
7.2.4. North America Market Size And Forecast, By Application
7.2.5. North America Market Size And Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.2. France
7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.3. UK
7.3.2.3.1. UK Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.3.2. UK Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.3.3. UK Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.4. Italy
7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.5. Rest of Europe
7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User
7.3.3. Europe Market Size And Forecast, By Product
7.3.4. Europe Market Size And Forecast, By Application
7.3.5. Europe Market Size And Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.2. China
7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.3. India
7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User
7.4.3. Asia-Pacific Market Size And Forecast, By Product
7.4.4. Asia-Pacific Market Size And Forecast, By Application
7.4.5. Asia-Pacific Market Size And Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.2. South Africa
7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.4.2. Rest of LAMEA Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.4.3. Rest of LAMEA Pharmaceutical Continuous Manufacturing Market, By End User
7.5.3. LAMEA Market Size And Forecast, By Product
7.5.4. LAMEA Market Size And Forecast, By Application
7.5.5. LAMEA Market Size And Forecast, By End User

Chapter 8: Company Profiles
8.1. Coperion Gmbh
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments
8.2. Gea Group Ag
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.3. Gebrüder Lödige Maschinenbau Gmbh
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.4. Glatt Gmbh
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.5. Hosokawa Micron Corporation
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Product Portfolio
8.5.4. Business Performance
8.6. Korsch Ag
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.7. L.B. Bohle Maschinen + Verfahren Gmbh
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.8. Munson Machinery Company, Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.9. Robert Bosch Packaging Technology Gmbh
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Coperion GmbH
  • GEA Group AG
  • Glatt GmbH
  • Korsch AG
  • Thermo Fisher Scient
  • MORE
According to the report titled, 'Pharmaceutical Continuous Manufacturing Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026', the global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is expected to reach $855 million by 2026, growing at a CAGR of 10.2% from 2019 to 2026.

Continuous manufacturing is an advanced manufacturing approach to provide pharmaceutical products with enhanced quality, improved yield, reduced cost within shorter time period. Pharmaceutical continuous manufacturing market is expected to witness significant grow growth during the forecast period, due to an increase in adoption of continuous manufacturing systems over the existing drug manufacturing process, technological advancements, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing for modernizing pharmaceutical manufacturing, and advantage over the batch manufacturing. However, higher cost of pharmaceutical continuous manufacturing systems restrain the market growth.

Depending on product, the market is categorized into integrated continuous systems, semi-continuous systems, and control & software. Presently, the integrated continuous systems dominates the global market, and is anticipated to continue this trend over the forecast period. This is attributed to rise in adoption of integrated continuous manufacturing (ICM) systems, technological advancements, and rise in preference for ICM systems as compared to the existing drug manufacturing systems.

By application, the global pharmaceutical continuous manufacturing market size is segregated into final drug product manufacturing and API manufacturing. At present, the final drug product manufacturing segment is the major revenue generator, and is anticipated to experience significant growth during the forecast period due to a surge in adoption of continuous manufacturing systems in pharmaceutical companies to improve yield, reduced cost of pharmaceutical substances, and to develop drugs within shorter time.

Key Findings of the Pharmaceutical Continuous Manufacturing Market:

On the basis of product, the integrated continuous systems segment held more than 60% share in the global market in 2018.
By end user, the pharmaceutical companies segment exhibits fastest growth, and is expected to grow at a CAGR of 10.7% from 2019 to 2026.
Depending on application, the final drug product manufacturing segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 11.5% during the forecast period.
North America accounted for approximately one-half of the global pharmaceutical continuous manufacturing market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to higher adoption of pharmaceutical continuous manufacturing systems, increase in presence of pharmaceutical companies, availability of well-developed healthcare infrastructure, wide availability of advanced pharmaceutical continuous manufacturing systems, and supportive government policies for adoption of continuous manufacturing systems. However, Asia-Pacific is expected to experience fastest pharmaceutical continuous manufacturing market growth during the forecast period, majorly due to an increase in adoption of pharmaceutical continuous manufacturing systems.
Note: Product cover images may vary from those shown
5 of 5
  • Bosch Packaging Technology
  • Coperion GmbH
  • GEA Group AG
  • Gebrüder Lödige Maschinenbau GmbH
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Munson Machinery Company Inc.
  • Thermo Fisher Scient
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll